Peter Silberstein, MD

Article

Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis

Author:

Abubakar Tauseef, MD

Maryam Zafar, MBBS

Peter Silberstein, MD

Joseph Nahas, MD

Thomas Frederickson, MD

Sean Hansen, MD

Anum Abbas, MD

Yaman Alali, MD

Avdesh Buragadda, MD

Omar K. Abughanimeh, MD

Sunil Nair, MD

Joseph Thirumalareddy, MD

Mohsin Mirza, MBBS

This meta-analysis showed that mutant epidermal growth factor receptor–tyrosine kinase inhibitors have an incidence of adverse effects that is...

• Read More